Literature DB >> 21089073

Characterization of Pitx2c expression in the mouse heart using a reporter transgene.

Milena B Furtado1, Christine Biben, Hidetaka Shiratori, Hiroshi Hamada, Richard P Harvey.   

Abstract

To aid in detection and tracking of cells targeted by the left-right (LR) pathway in the heart throughout morphogenesis, expression from a Pitx2c-lacZ transgene (P2Ztg) was analysed in detail. β-galactosidase expression from P2Ztg was robust, allowing reliable visualisation of low-level Pitx2c expression, and was virtually entirely dependent upon NODAL signalling in the heart. P2Ztg showed expression in trabecular and septal, as well as non-trabecular, myocardium, and a strong expression bias in myocardium associated with individual endocardial cushions of the atrioventricular canal and outflow tract, which are essential for cardiac septation. Expression on the ventral surface of the outflow tract evolved to a specific stripe that could be used to track the future aorta during outflow tract spiralling and remodelling. Our data show that the P2Ztg transgene is a useful resource for detection of molecular disturbances in the LR cascade, as well as morphogenetic defects associated with other cardiac congenital disorders.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21089073     DOI: 10.1002/dvdy.22492

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  12 in total

1.  Hyperglycemia impairs left-right axis formation and thereby disturbs heart morphogenesis in mouse embryos.

Authors:  Masahiro Hachisuga; Shinya Oki; Keiko Kitajima; Satomi Ikuta; Tomoyuki Sumi; Kiyoko Kato; Norio Wake; Chikara Meno
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

2.  Pitx2 is a critical early regulatory gene in normal cecal development.

Authors:  Peter F Nichol; Yukio Saijoh
Journal:  J Surg Res       Date:  2011-04-13       Impact factor: 2.192

3.  Utility and limits of Hprt-Cre technology in generating mutant mouse embryos.

Authors:  Krzysztof M Zaremba; Amy L Reeder; Anna Kowalkowski; Eden Girma; Peter F Nichol
Journal:  J Surg Res       Date:  2013-10-29       Impact factor: 2.192

4.  MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1.

Authors:  Ralston M Barnes; Ian S Harris; Eric J Jaehnig; Kimberly Sauls; Tanvi Sinha; Anabel Rojas; William Schachterle; David J McCulley; Russell A Norris; Brian L Black
Journal:  Development       Date:  2016-01-25       Impact factor: 6.868

5.  Prevalence and spectrum of PITX2c mutations associated with congenital heart disease.

Authors:  Juan Wang; Yuan-Feng Xin; Wen-Jun Xu; Zhong-Min Liu; Xing-Biao Qiu; Xin-Kai Qu; Lei Xu; Xin Li; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2013-10-01       Impact factor: 3.311

6.  Long-range regulatory interactions at the 4q25 atrial fibrillation risk locus involve PITX2c and ENPEP.

Authors:  Luis A Aguirre; M Eva Alonso; Claudio Badía-Careaga; Isabel Rollán; Cristina Arias; Ana Fernández-Miñán; Elena López-Jiménez; Amelia Aránega; José Luis Gómez-Skarmeta; Diego Franco; Miguel Manzanares
Journal:  BMC Biol       Date:  2015-04-17       Impact factor: 7.431

7.  PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome.

Authors:  Cui-Mei Zhao; Lu-Ying Peng; Li Li; Xing-Yuan Liu; Juan Wang; Xian-Ling Zhang; Fang Yuan; Ruo-Gu Li; Xing-Biao Qiu; Yi-Qing Yang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 8.  Multiple Roles of Pitx2 in Cardiac Development and Disease.

Authors:  Diego Franco; David Sedmera; Estefanía Lozano-Velasco
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-11

Review 9.  Current Perspectives in Cardiac Laterality.

Authors:  Marina Campione; Diego Franco
Journal:  J Cardiovasc Dev Dis       Date:  2016-12-09

10.  PITX2c loss-of-function mutations responsible for congenital atrial septal defects.

Authors:  Fang Yuan; Lan Zhao; Juan Wang; Wei Zhang; Xin Li; Xing-Biao Qiu; Ruo-Gu Li; Ying-Jia Xu; Lei Xu; Xing-Kai Qu; Wei-Yi Fang; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2013-08-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.